Showing results (331-340 of 404) with videos related to

Sort By:
Pageof 41
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancerHoward L Kaufman, Heinz-Josef Lenz, John Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trialWilliam Small, Jordan Berlin, Gary M Freedman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2020
Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)Li Ren, Dexiang Zhu, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapiesAlan P Venook, Maria E Arcila, Al B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2018
Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)Temidayo Fadelu, Sui Zhang, Donna Niedzwiecki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN task force: clinical utility of PET in a variety of tumor typesDonald A Podoloff, Douglas W Ball, Edgar Ben-Josef, et al.
JAMA Network Open|February 22, 2022
Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon CancerErin L Van Blarigan, Fang-Shu Ou, Tiffany M Bainter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 StudyPhilip A Philip, Vaibhav Sahai, Nathan Bahary, et al.
Pageof 41